Targeted delivery systems for oligonucleotide therapeutics

AAPS J. 2009 Mar;11(1):195-203. doi: 10.1208/s12248-009-9096-1. Epub 2009 Mar 19.

Abstract

Oligonucleotides including antisense oligonucleotides and siRNA are emerging as promising therapeutic agents against a variety of diseases. Effective delivery of these molecules is critical to their successful clinical application. Targeted systems can greatly improve the efficiency and specificity of oligonucleotides delivery. Meanwhile, an effective delivery system must successfully overcome a multitude of biological barriers to enable the oligonucleotides to reach the site of action and access their biological targets. Several delivery strategies based on different platform technologies and different targeting ligands have been developed to achieve these objectives. This review aims at providing a summary and perspective on recent progress in this very active area of research.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / administration & dosage
  • Carrier Proteins / drug effects
  • Drug Carriers
  • Drug Delivery Systems*
  • Drug Stability
  • Folate Receptors, GPI-Anchored
  • Folic Acid / administration & dosage
  • Folic Acid / pharmacokinetics
  • Genetic Vectors
  • Humans
  • Immunoconjugates / administration & dosage
  • Immunoconjugates / pharmacokinetics
  • Ligands
  • Lipoproteins / administration & dosage
  • Lipoproteins / pharmacokinetics
  • Liposomes
  • Mice
  • Neoplasms / drug therapy
  • Oligonucleotides / administration & dosage*
  • Oligonucleotides / therapeutic use
  • Oligonucleotides, Antisense / administration & dosage
  • Oligonucleotides, Antisense / therapeutic use
  • Peptides / administration & dosage
  • Peptides / pharmacokinetics
  • RNA, Small Interfering / administration & dosage
  • RNA, Small Interfering / therapeutic use
  • Receptors, Cell Surface / drug effects
  • Tissue Distribution
  • Transferrin / administration & dosage
  • Transferrin / pharmacokinetics

Substances

  • Antibodies, Monoclonal
  • Carrier Proteins
  • Drug Carriers
  • Folate Receptors, GPI-Anchored
  • Immunoconjugates
  • Ligands
  • Lipoproteins
  • Liposomes
  • Oligonucleotides
  • Oligonucleotides, Antisense
  • Peptides
  • RNA, Small Interfering
  • Receptors, Cell Surface
  • Transferrin
  • Folic Acid